Network Health Intervention for Adolescents Leaving Acute Psychiatric Care

April 12, 2024 updated by: Ian Cero, University of Rochester
The purpose of this pilot study is to refine and then assess the feasibility, acceptability, and target engagement of Acute Youth Connect - a network health intervention for adolescents leaving acute psychiatric care with suicide-related concerns.

Study Overview

Status

Terminated

Conditions

Intervention / Treatment

Detailed Description

This pilot study includes only one arm of subjects, all of whom will receive Acute Youth Connect, in addition to treatment as usual. The Acute Youth Connect treatment protocol lasts for 12 weeks following discharge, for a total intervention period of roughly 13 weeks including pre-discharge consent and nomination of supports. Patients will be assessed at baseline, mid-intervention, immediately post-intervention, and 12 weeks following the scheduled intervention completion.

Feedback from the first 5-10 patients will be used to modify the treatment protocol to improve patient acceptability. All remaining patients will receive this refined treatment protocol.

At the time of registration, the Acute Youth Connect treatment protocol is as follows. Adolescents in acute psychiatric care (partial hospitalization) will be screened for eligibility approximately one week before discharge. After patient assent and parental consent are received, the patient and a parent/caregiver will together nominate 3-4 trusted adults in the patient's life to serve as a post-discharge support team. The nominees will then be contacted, consented, and receive a 45-90 minute training on how to provide social support to the patient. Each adult support will also receive weekly (3-15 minute) check in calls from study staff to monitor progress and resolve any concerns related to the patient's progress. In addition, each patient will attend 3 interactive sessions with a study interventionist, and will be encouraged to bring an adult from their support team to participate as well. These sessions will be evenly spaced throughout the post-discharge intervention period. Adolescents will receive weekly reflection-prompting text messages to practice skills taught in the interactive sessions.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Rochester, New York, United States, 14642
        • University of Rochester Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Description

Youth subjects will be included if:

  • Youth subject is being discharged from the Child and Adolescent Partial Hospital Service (CAPHS) in the URMC Department of Psychiatry.
  • Youth subject endorses past year suicide attempt OR past year suicidal ideation at time of partial hospitalization, as assessed on standardized intake questionnaire used by CAPHS.
  • Youth subject has a cellular phone, with an active service plan, that is capable of sending and receiving standard SMS text messages.
  • Youth subject is aged 12 - 18 at time of enrollment.

Youth subjects will be excluded if:

  • Youth subject has medical or psychiatric comorbidities that impair ability to assent (e.g., active psychotic or manic episode, cognitive impairment).
  • Youth subject patient or guardian does not speak fluent English, as meeting translation costs is not possible in this study.
  • Youth subject is unable to name at least 2 trusted adults (at least 1 of which is not a parent or caregiver) they would like to serve on their support team.
  • Youth is unable or unwilling to share their suicide-related safety plan

Parent / legal guardian subjects will be included if:

- Adult subject is at least 21 years of age.

Adult support team subjects will be included if:

  • Adult subject is nominated by a youth subject to serve on their adult support team
  • Adult subject is approved by youth subject's parent or legal guardian
  • Adult subject has a cellular phone, with an active service plan, that is capable of sending and receiving standard SMS text messages.
  • Adult subject is at least 21 years of age.

Adult support team subjects will be excluded if:

  • Adult subject has medical or psychiatric comorbidities that impair ability to consent (e.g., active psychotic or manic episode, cognitive impairment).
  • Adult subject does not speak fluent English, as meeting translation costs is not possible in this study.
  • Adult reports being unable to be in contact with youth at least once per week, for the 12 weeks of the intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Acute Youth Connect + TAU
Subjects will receive 12 weeks of post-discharge Acute Youth Connect intervention, in addition to regular post-discharge treatment as usual.
This intervention is being piloted will be revised with feedback from the first 5-10 patients who complete it. At the time of registration, the protocol is as follows: Roughly one week prior to discharge, the patient and a parent/caregiver will together nominate 3-4 trusted adults in the patient's life to serve as their post-discharge support team. Consenting nominees will then attend a 45-90 minute training on how to provide social support to the patient. Each adult support will also receive weekly (3-15 minute) check in calls from study staff to monitor progress and concerns. Each patient will also attend 3 interactive sessions with a study interventionist, and will be encouraged to bring an adult from their support team. These sessions will be evenly spaced throughout the post-discharge intervention period. Adolescents will receive weekly reflection-prompting text messages to practice skills taught in the interactive sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of youth who complete the intervention
Time Frame: Interactive sessions by the end of the 12-week intervention.
Youth subjects who complete all three interactive sessions will be marked as "treatment completers."
Interactive sessions by the end of the 12-week intervention.
Text message responses
Time Frame: A text message must be responded to before the next text message prompt is sent (roughly one week).
Text message prompts will be marked as "responded to" when a recipient produces at least one reply.
A text message must be responded to before the next text message prompt is sent (roughly one week).
Adult support team treatment completion
Time Frame: Psychoeducation sessions must be completed before week 4 after youth's discharge. Check-in calls must be completed in seperatecalendar weeks, all before the end of the 12-week intervention.
Adult support team members who complete their initial psychoeducation training session and complete 75% of their check-in phone calls will be marked as "treatment completers".
Psychoeducation sessions must be completed before week 4 after youth's discharge. Check-in calls must be completed in seperatecalendar weeks, all before the end of the 12-week intervention.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in weekly contact to supportive adults in their lives
Time Frame: Baseline to post-treatment, approximately 3 months
Youth subjects will report a change in the average weekly contact with the members of their adult support team, compared to reported baseline contact.
Baseline to post-treatment, approximately 3 months
Change in weekly contact to supportive adults in their lives
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Youth subjects will report a change in the average weekly contact with the members of their adult support team, compared to reported baseline contact.
Baseline to 3 months post-treatment, approximately 6 months
Utilization of intervention content
Time Frame: Baseline to post-treatment, approximately 3 months
Rate of adolescents reporting using at least two of the three Acute Youth Connect cores (connection, balance, purpose) weekly or more.
Baseline to post-treatment, approximately 3 months
Utilization of intervention content
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Rate of adolescents reporting using at least two of the three Acute Youth Connect cores (connection, balance, purpose) weekly or more.
Baseline to 3 months post-treatment, approximately 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in perceived social connectedness
Time Frame: Baseline to post-treatment, approximately 3 months
Interpersonal Needs Questionnaire - Belongingness subscale. Total scores range from 0-54, higher scores indicate more social distress. We predict a change in distress.
Baseline to post-treatment, approximately 3 months
Change in perceived social connectedness
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Interpersonal Needs Questionnaire - Belongingness subscale. Total scores range from 0-54, higher scores indicate more social distress. We predict a change in distress.
Baseline to 3 months post-treatment, approximately 6 months
Change in feelings of meaning
Time Frame: Baseline to post-treatment, approximately 3 months
Claremont Purpose Scale - Personal Meaning subscale. Total scores range from 0-16 for each subscale scale. Higher scores indicate more feelings of meaning and purpose. We predict a change in scores on each subscale.
Baseline to post-treatment, approximately 3 months
Change in feelings of meaning
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Claremont Purpose Scale - Personal Meaning subscale. Total scores range from 0-16 for each subscale scale. Higher scores indicate more feelings of meaning and purpose. We predict a change in scores on each subscale.
Baseline to 3 months post-treatment, approximately 6 months
Change in feelings of purpose
Time Frame: Baseline to post-treatment, approximately 3 months
Claremont Purpose Scale - Goal-directedness subscale. Total scores range from 0-16 for each subscale scale. Higher scores indicate more feelings of meaning and purpose. We predict a change in scores on each subscale.
Baseline to post-treatment, approximately 3 months
Change in feelings of purpose
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Claremont Purpose Scale - Goal-directedness subscale. Total scores range from 0-16 for each subscale scale. Higher scores indicate more feelings of meaning and purpose. We predict a change in scores on each subscale.
Baseline to 3 months post-treatment, approximately 6 months
Changes in interpersonal emotion regulation
Time Frame: Baseline to post-treatment, approximately 3 months
Interpersonal Emotion Regulation Questionnaire - Social Modeling Subscale (scores range from 5-25, higher scores indicate improved functioning). We predict a change in scores.
Baseline to post-treatment, approximately 3 months
Changes in interpersonal emotion regulation
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Interpersonal Emotion Regulation Questionnaire - Social Modeling Subscale (scores range from 5-25, higher scores indicate improved functioning). We predict a change in scores.
Baseline to 3 months post-treatment, approximately 6 months
Changes in access to emotion regulation strategies
Time Frame: Baseline to post-treatment, approximately 3 months
Difficulties in Emotion Regulation Scale - Regulation Strategies Subscale (scores range from 3-15, higher scores indicate greater dysfunction). We predict a change in scores.
Baseline to post-treatment, approximately 3 months
Changes in access to emotion regulation strategies
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Difficulties in Emotion Regulation Scale - Regulation Strategies Subscale (scores range from 3-15, higher scores indicate greater dysfunction). We predict a change in scores.
Baseline to 3 months post-treatment, approximately 6 months
Changes in engagement with healthy activities
Time Frame: Baseline to post-treatment, approximately 3 months
Behavioral Activation for Depression - Short form - Activation Subscale. Scores range from 5-35, with higher scores indicating greater function. We predict a change in function.
Baseline to post-treatment, approximately 3 months
Changes in engagement with healthy activities
Time Frame: Baseline to 3 months post-treatment, approximately 6 months
Behavioral Activation for Depression - Short form - Activation Subscale. Scores range from 5-35, with higher scores indicating greater function. We predict a change in function.
Baseline to 3 months post-treatment, approximately 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ian Cero, PhD, University of Rochester

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2022

Primary Completion (Actual)

October 6, 2023

Study Completion (Actual)

October 6, 2023

Study Registration Dates

First Submitted

March 3, 2022

First Submitted That Met QC Criteria

April 18, 2022

First Posted (Actual)

April 22, 2022

Study Record Updates

Last Update Posted (Actual)

April 16, 2024

Last Update Submitted That Met QC Criteria

April 12, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00006651
  • 2KL2TR001999-05 (U.S. NIH Grant/Contract)
  • https://osf.io/8pd54/ (Other Identifier: Open Science Foundation)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

There is no current plan to share IPD with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide, Attempted

Clinical Trials on Acute Youth Connect

Subscribe